Endocan is a modern biomarker and could emerge as an innovative parameter to evaluate the associated risks in COVID-19 patients; nevertheless, more studies are needed to assess the relationship with inflammatory and thrombosis markers (CRP, fibrinogen, D dimers, IL 6) or CT scans. The gene discussed is CRP; the disease is deep vein thrombosis.